Monnieriside G is primarily studied for its potential biological activities, particularly in the field of natural product-based drug discovery. It has shown promising antioxidant properties, which may contribute to cellular protection against oxidative stress. Research also indicates possible anti-inflammatory effects, making it a candidate for further investigation in treating inflammatory-related conditions. Due to its complex glycosidic structure, it is of interest in structure-activity relationship studies, especially in optimizing natural compounds for enhanced bioavailability and therapeutic efficacy. Currently, its applications remain within preclinical research, focusing on pharmacological potential and biosynthetic pathways in plant sources.